HERON THERAPEUTICS, INC. /DE/ Pre-Tax Income
HERON THERAPEUTICS, INC. /DE/ (HRTX) reported Pre-Tax Income of -$4.83 million for the 3-month period ending 2012-03-31, per its 10-Q filed 2012-05-10.
Discontinued › Income Statement
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest · last filed 2012-05-10
- HERON THERAPEUTICS, INC. /DE/ income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2012-03-31 was -$4.83M.
- HERON THERAPEUTICS, INC. /DE/ income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2011-03-31 was -$1.32M.
- HERON THERAPEUTICS, INC. /DE/ income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2011 was -$11.44M.
- HERON THERAPEUTICS, INC. /DE/ income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2010 was -$7.20M.
- HERON THERAPEUTICS, INC. /DE/ income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2009 was -$10.22M.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 3 month | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 12 month |
|---|---|---|
| 2012-03-31 | -$4.83M 10-Q · filed 2012-05-10 | |
| 2011-12-31 | -$11.44M 10-K · filed 2012-03-26 | |
| 2011-03-31 | -$1.32M 10-Q · filed 2012-05-10 | |
| 2010-12-31 | -$7.20M 10-K · filed 2012-03-26 | |
| 2009-12-31 | -$10.22M 10-K · filed 2012-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Lite Strategy, Inc. (LITS) | United States | $0.049B |